Laboratory Analyzers Segment to Lead Hemostasis Analyzers Market During 2021–2028
According to our latest study on “Hemostasis Analyzers Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Test, and End User,” the market is projected to reach US$ 6,490.24 million by 2028 from US$ 3,440.66 million in 2021; it is expected to register a CAGR of 9.5% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the market.
Based on product type, the hemostasis analyzers market is segmented into facial laboratory analyzers and point-of-care testing systems. The laboratory analyzer segment held a larger market share in 2021, and it is also expected to witness the highest CAGR during the forecast period.
Siemens AG; Instrumentation Laboratory; Abbott; Sysmex Corporation; Nihon Kohden Corporation; Thermo Fisher Scientific, Inc.; Roche Diagnostics; Diagnostica Stago; Helena Laboratories; and International Technidyne Corporation are among the leading companies operating in the hemostasis analyzers market.
Hemostasis Analyzers Market Share, by Region, 2021 (%)
Hemostasis Analyzers Market Statistics Report 2028
Download Free Sample
Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Laboratory Analyzer (Automated Systems, Semi-Automated Systems, and Manual Systems) and Point-of-Care Testing Systems], Test [Activated Partial Thromboplastin Time, D-Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, and Others], and End User (Hospitals/Clinics, Independent Diagnostic Laboratories, Home Care Setting, and Others)
Hemostasis Analyzers Market Statistics Report 2028
Download Free SampleHemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Laboratory Analyzer (Automated Systems, Semi-Automated Systems, and Manual Systems) and Point-of-Care Testing Systems], Test [Activated Partial Thromboplastin Time, D-Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, and Others], and End User (Hospitals/Clinics, Independent Diagnostic Laboratories, Home Care Setting, and Others)
The hemostasis analyzers market is segmented based on product type, test, and end user. Based on product type, the hemostasis analyzers market is segmented into laboratory analyzers and point-of-care testing systems. Based on the test, the market is segmented into activated partial thromboplastin time, D-Dimer test, fibrinogen test, prothrombin time test, and others. Based on end user, the market is segmented into hospitals/clinics, independent diagnostic laboratories, home care settings, and others.
In terms of geography, the hemostasis analyzers market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com